ZA200303446B - New process. - Google Patents
New process. Download PDFInfo
- Publication number
- ZA200303446B ZA200303446B ZA200303446A ZA200303446A ZA200303446B ZA 200303446 B ZA200303446 B ZA 200303446B ZA 200303446 A ZA200303446 A ZA 200303446A ZA 200303446 A ZA200303446 A ZA 200303446A ZA 200303446 B ZA200303446 B ZA 200303446B
- Authority
- ZA
- South Africa
- Prior art keywords
- process according
- compound
- formula
- acid
- eletriptan
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 25
- 150000001875 compounds Chemical class 0.000 claims description 21
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 14
- OTLDLQZJRFYOJR-LJQANCHMSA-N eletriptan Chemical compound CN1CCC[C@@H]1CC1=CN=C2[C]1C=C(CCS(=O)(=O)C=1C=CC=CC=1)C=C2 OTLDLQZJRFYOJR-LJQANCHMSA-N 0.000 claims description 12
- 229960002472 eletriptan Drugs 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 238000006722 reduction reaction Methods 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 5
- 238000010531 catalytic reduction reaction Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- UJTPZISIAWDGFF-UHFFFAOYSA-N ethenylsulfonylbenzene Chemical compound C=CS(=O)(=O)C1=CC=CC=C1 UJTPZISIAWDGFF-UHFFFAOYSA-N 0.000 claims description 3
- 229910052763 palladium Inorganic materials 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- JCXOJXALBTZEFE-GFCCVEGCSA-N 5-bromo-3-[[(2r)-1-methylpyrrolidin-2-yl]methyl]-1h-indole Chemical compound CN1CCC[C@@H]1CC1=CNC2=CC=C(Br)C=C12 JCXOJXALBTZEFE-GFCCVEGCSA-N 0.000 claims description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 claims description 2
- 229910003446 platinum oxide Inorganic materials 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims 1
- 239000007868 Raney catalyst Substances 0.000 claims 1
- 229910000564 Raney nickel Inorganic materials 0.000 claims 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- JXGVXCZADZNAMJ-LLVKDONJSA-N (2r)-1-phenylmethoxycarbonylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCCN1C(=O)OCC1=CC=CC=C1 JXGVXCZADZNAMJ-LLVKDONJSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- VXWVFZFZYXOBTA-UHFFFAOYSA-N 5-bromo-1h-indole Chemical compound BrC1=CC=C2NC=CC2=C1 VXWVFZFZYXOBTA-UHFFFAOYSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229940124433 antimigraine drug Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0031094.6A GB0031094D0 (en) | 2000-12-20 | 2000-12-20 | New Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200303446B true ZA200303446B (en) | 2004-07-05 |
Family
ID=9905487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200303446A ZA200303446B (en) | 2000-12-20 | 2003-05-06 | New process. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1373254B1 (ja) |
| JP (1) | JP2004516290A (ja) |
| KR (1) | KR20030061448A (ja) |
| CN (1) | CN1199969C (ja) |
| AR (2) | AR035406A1 (ja) |
| AT (1) | ATE308539T1 (ja) |
| AU (1) | AU2002218440A1 (ja) |
| BR (1) | BR0116324A (ja) |
| CA (1) | CA2432138C (ja) |
| CZ (1) | CZ20031640A3 (ja) |
| DE (1) | DE60114668T2 (ja) |
| ES (1) | ES2249386T3 (ja) |
| GB (1) | GB0031094D0 (ja) |
| HU (1) | HUP0302465A2 (ja) |
| IL (1) | IL155706A0 (ja) |
| MX (1) | MXPA03005569A (ja) |
| PL (1) | PL362716A1 (ja) |
| RU (1) | RU2256660C2 (ja) |
| WO (1) | WO2002050063A1 (ja) |
| ZA (1) | ZA200303446B (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927296B2 (en) | 2003-07-23 | 2005-08-09 | Pfizer Inc. | Process |
| EP2093225A1 (en) * | 2007-05-01 | 2009-08-26 | Plus Chemicals B.V. | Process for preparing crystalline eletriptan hydrobromide form ß |
| IT1393700B1 (it) * | 2009-04-22 | 2012-05-08 | F S I Fabbrica Italiana Sint | Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo |
| WO2011024039A1 (en) * | 2009-08-25 | 2011-03-03 | Ramesh Babu Potluri | Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives |
| US8754239B2 (en) | 2010-01-19 | 2014-06-17 | Sms Pharmaceuticals Limited | Process for preparing eletriptan hydrobromide having α-form |
| WO2012004811A1 (en) * | 2010-07-06 | 2012-01-12 | Ind-Swift Laboratories Limited | Process for the preparation of 5-substsituted indole derivative |
| WO2017125351A1 (en) | 2016-01-21 | 2017-07-27 | Laboratorios Lesvi Sl | Process for preparing (( r)-3-[(-1-methylpyrrolidin-2-yl)methyl]-5-(2-phenylsulfonylethyl)-1h-indole |
| CN112440631B (zh) * | 2020-11-02 | 2022-09-13 | 长城汽车股份有限公司 | 一种调节胎压装置、方法、系统以及车辆 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU651637B2 (en) * | 1990-10-15 | 1994-07-28 | Pfizer Inc. | Indole derivatives |
-
2000
- 2000-12-20 GB GBGB0031094.6A patent/GB0031094D0/en not_active Ceased
-
2001
- 2001-12-06 HU HU0302465A patent/HUP0302465A2/hu unknown
- 2001-12-06 EP EP01271106A patent/EP1373254B1/en not_active Expired - Lifetime
- 2001-12-06 CA CA002432138A patent/CA2432138C/en not_active Expired - Fee Related
- 2001-12-06 KR KR10-2003-7008081A patent/KR20030061448A/ko not_active Application Discontinuation
- 2001-12-06 AT AT01271106T patent/ATE308539T1/de not_active IP Right Cessation
- 2001-12-06 WO PCT/IB2001/002338 patent/WO2002050063A1/en active IP Right Grant
- 2001-12-06 ES ES01271106T patent/ES2249386T3/es not_active Expired - Lifetime
- 2001-12-06 MX MXPA03005569A patent/MXPA03005569A/es active IP Right Grant
- 2001-12-06 RU RU2003118330/04A patent/RU2256660C2/ru not_active IP Right Cessation
- 2001-12-06 PL PL01362716A patent/PL362716A1/xx not_active Application Discontinuation
- 2001-12-06 CN CNB018199674A patent/CN1199969C/zh not_active Expired - Fee Related
- 2001-12-06 IL IL15570601A patent/IL155706A0/xx unknown
- 2001-12-06 JP JP2002551559A patent/JP2004516290A/ja active Pending
- 2001-12-06 DE DE60114668T patent/DE60114668T2/de not_active Expired - Fee Related
- 2001-12-06 CZ CZ20031640A patent/CZ20031640A3/cs unknown
- 2001-12-06 BR BR0116324-8A patent/BR0116324A/pt not_active IP Right Cessation
- 2001-12-06 AU AU2002218440A patent/AU2002218440A1/en not_active Abandoned
- 2001-12-18 AR ARP010105858A patent/AR035406A1/es unknown
-
2003
- 2003-05-06 ZA ZA200303446A patent/ZA200303446B/en unknown
-
2004
- 2004-02-03 AR ARP040100334A patent/AR043016A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR035406A1 (es) | 2004-05-26 |
| AR043016A2 (es) | 2005-07-13 |
| EP1373254A1 (en) | 2004-01-02 |
| AU2002218440A1 (en) | 2002-07-01 |
| CN1199969C (zh) | 2005-05-04 |
| CA2432138A1 (en) | 2002-06-27 |
| MXPA03005569A (es) | 2003-10-06 |
| JP2004516290A (ja) | 2004-06-03 |
| GB0031094D0 (en) | 2001-01-31 |
| PL362716A1 (en) | 2004-11-02 |
| ES2249386T3 (es) | 2006-04-01 |
| HUP0302465A2 (hu) | 2003-12-29 |
| KR20030061448A (ko) | 2003-07-18 |
| EP1373254B1 (en) | 2005-11-02 |
| BR0116324A (pt) | 2003-10-14 |
| CN1487932A (zh) | 2004-04-07 |
| RU2256660C2 (ru) | 2005-07-20 |
| CZ20031640A3 (cs) | 2004-08-18 |
| ATE308539T1 (de) | 2005-11-15 |
| DE60114668D1 (de) | 2005-12-08 |
| WO2002050063A1 (en) | 2002-06-27 |
| CA2432138C (en) | 2007-05-08 |
| DE60114668T2 (de) | 2006-07-20 |
| IL155706A0 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0010232A (pt) | Catalisador e processo para preparação de acetato de vinila | |
| ZA200303446B (en) | New process. | |
| NO20020961L (no) | Fremgangsmåte for metanolkarbonylisering med forbedret forurensningsprofil ved anvendelse av katalysatorsystem medrhodium og uorganisk jodid | |
| RU2000127718A (ru) | Способ получения уксусной кислоты | |
| US20030166704A1 (en) | New process | |
| JP2004520312A5 (ja) | ||
| US20090093653A1 (en) | Catalyst | |
| RU2003118330A (ru) | Новый способ | |
| CN101307006B (zh) | 4-(n,n-二甲氨基)丁醛缩二甲醇的合成方法 | |
| HRP20050501A2 (en) | Method for producing salts of tolperisone | |
| JP4863592B2 (ja) | 酢酸及び／又は酢酸メチル製造中における触媒の安定性の向上及び／又は不活性化の防止方法 | |
| CN114588929A (zh) | 一种负载型铜纳米团簇催化剂及其在aha偶联反应中的应用 | |
| CN115340481A (zh) | 一种采用固载镍催化工业化生产氘代医药中间体的方法 | |
| EP1273564A3 (de) | Verfahren zur Herstellung von Aldehyden | |
| JPH09505079A (ja) | Ｎ−置換されたグリシンまたはグリシンエステルの製造方法ならびにインジゴ合成方法への適用 | |
| Maleski | Improved procedures for the preparation of 2-nitro-5-methoxyphenol and 6-methoxy-2 (3H)-benzoxazolone from 3-methoxyphenol | |
| EP2328870A1 (en) | Method for the preparation of 3-methylpyridine | |
| JP4788027B2 (ja) | アミノピロリジン誘導体の製造法 | |
| JPS5946274A (ja) | ２−アルキル−４−アミノ−５−アミノメチルピリミジンの製法 | |
| JP2007176824A (ja) | 不斉還元方法 | |
| JP2003528067A (ja) | オレフィンからアルコールを調製するための方法 | |
| JP2004115437A (ja) | Ｌ−フェニレフリンを製造する方法 | |
| Kaiser | Gulf'sdead zone'worries agencies. | |
| JPS5973567A (ja) | インド−ル類の製造方法 | |
| RU2004117584A (ru) | Способ получения серотонина и его фармакологически приемлемых солей |